Joyn Bio is a joint venture founded to bring synthetic biology to the challenges of sustainability in agriculture, including engineering microbes that can provide plants with biological nitrogen fertilizer.
Timeline
March 2018
Joyn Bio raises a $100,000,000 series A round from Bayer, Ginkgo Bioworks and Viking Global Investors.
September 14, 2017
Joyn Bio raises a $100,000,000 series A round from Bayer, Ginkgo Bioworks and Viking Global Investors.
Funding Rounds
Patents
Further Resources
Title
Author
Link
Type
Date
References
Organization
CompanyCompany attributes
Biotechnology
Synthetic biology
Agriculture
HealthcareLocation
Boston
Woodland, CaliforniaCompany Operating Status
Active
B2X
B2B
Reshma Shetty (entrepreneur)
Jason KellyPitchbook URL
Legal Name
Joyn Bio Inc.
Parent Organization
BayerLegal classification
Incorporation (business)Number of Employees (Ranges)
50 – 99
Number of Employees
78
Full Address
27 Drydock Ave Ste 8 Boston, MA, 02210-2383 United State
37437 CA-16 Woodland, CA 95695
Viking Global Investors
Ginkgo BioworksFounded Date
September 2017
Email Address
info@joynbio.com
Total Funding Amount (USD)
200,000,000
Latest Funding Round Date
March 2018
Impact Biomedicines
METiS TherapeuticsBoard of Directors
Latest Funding Type
Series A roundOther attributes
Country
United StatesCategories
Related Topics
Contributors
- 1
Victoria Siderea
✦ - 2
Aleksander Holm
Interested in understanding the world we live in. - 3
Alexander Baychikov
Entrepreneur, investor - 4
Joe Burns
My name is Joe Burns. I love technology, sports and writing! - 5
Duzenko Andrey
Extensive experience in development and interaction with the community - 6
Katrina-Kay Pettitt
Data Duchess @ Golden - 7
Dhruv Sharma
Researcher - 8
Bhupendra Solanki
Researcher
